Blog

Kinross Gold Reports 2022 Third-Quarter Results  Junior Mining Network
source

Immediately, you can tell something’s different. Approaching a 2023 Mercedes EQE, the future-pod design unabashedly looks ahead while the 2021 MotorTrend Car of the Year-winning E-Class wears a variation of a stylistic theme we’ve seen for more than half a century. The more we experienced the 2023 Mercedes EQE350 4Matic, the more we discovered it has a spirit all its own. In place of that E-Class magic is a luxury-first, -second, and -third package that beats the E on one metric but falters in others. Here’s why the 2023 Mercedes EQE350 4Matic isn’t an obvious choice.
Our 2023 Mercedes EQE350 4Matic test car sits in the middle of the non-AMG EQE lineup with its dual-motor all-wheel-drive layout; the plus on base models designates the rear-drive model that will get the best EPA-rated range figure, estimated at 305 miles. Figure below 300 for the EQE350 4Matic. Those numbers are great as long as you don’t also consider the higher-priced Tesla Model S and Lucid Air. Really, only one direct competitor exists in the EQE’s size and price class: the Genesis G80 Electric. The G80 EV has standard all-wheel drive and boasts 282 miles of range, but it lacks the variety of models Mercedes provides within the EQE lineup.
Higher in the EQE sedan range is the more powerful EQE500 4Matic model. At the top of the EQE line is the Mercedes-AMG EQE, which offers up to 677 hp from two motors. Back on earth, the EQE350 4Matic model makes 288 hp and 564 lb-ft of torque, figures that sound like an upgrade over the less powerful E350, but the electric Mercedes weighs 1,400 pounds more.
Despite that heavy truth, the EQE350 4Matic manages to match an E450 4Matic in 0-30-mph acceleration (1.6 seconds), and on to a 5.2-second 0-60 time. That’s not bad for a modern luxury car, but the dual-motor G80 Electric smokes it: The Genesis only needs 4.1 seconds to reach 60. The G80 is also slightly quicker to charge, with a 187-kW peak charge rate on a DC charger compared to the EQE350 4Matic’s 170-kW rate. You won’t notice this when you charge at home overnight, but on a road trip, we’ll take any quick-charging advantage we can get.
On the street, we felt the near-instant whoosh of speed you get in most other EVs, but it tapers off about halfway along your journey to 60. The EQE500 4Matic and AMG-ified EQE should feel quicker, but let’s have some perspective: The fact a 350-badged Mercedes hits 60 in less than 6.0 seconds is more than sufficient for most drivers. Considering the EQE350’s expected efficiency and range, it’s an OK tradeoff for a car with three other models available.
The rest of the 2023 Mercedes EQE350 4Matic’s driving experience doesn’t impress much. Braking from 60 to 0 mph required 117 feet, a respectable distance for a 5,484-pound car, but the brake feel was roundly criticized by editors as hard to judge on and off the track. Part of the issue is the same problem we’ve called out on other new electric Mercedes cars: The brake pedal moves to match the amount of regenerative braking happening at any time. Although the idea is to make the transition between regenerative and friction braking feel more natural, instead it often leads to situations where the pedal isn’t always where we expect it to be. We’re unsure we’d get used to this over time.
When challenged by uneven or poorly maintained road surfaces, the EQE350 also failed to live up to the EQS hatch’s very high ride-quality standard. Then again, maybe comparing the EQE dynamics to the EQS is unfair, so let’s compare apples to similarly priced apples. When driven around the same MotorTrend figure-eight course, the G80 Electric felt quite well composed for a gas-engine car converted to a full EV. As for the EQE350, it also felt heavy, but this wasn’t a positive. We noted its mushy brake pedal as well as gooey and imprecise steering. Unlike the E-Class, which beautifully balances luxury and sport in E450 form, the EQE350 is all-in on a luxury-first focus. That’s fine, but the experience wasn’t as sparkling as we’d like.
One bright spot is the Rear-Axle Steering system, technology we’ve seen on other Mercedes cars, too. On the EQE350, it has the same effect: It makes the car feel more maneuverable thanks to the rear wheels’ ability to rotate in the opposite direction to the fronts at low speeds. Our test car had the 10-degree version of the feature; a less extreme 4.5-degree system is also available.
Our Pinnacle-trim 2023 Mercedes EQE350 made a stunning first impression inside. Before some of us realized how the car’s high cowl limited outward visibility, we loved the beautiful combination of light brown seats, beige upper dash, and gray-brown matte-wood trim. Also, the turbine-style outer air vents are exquisite; it’s another rewarding detail that helps justify prices that start at $76,050 for a base EQE350+.
The biggest issue isn’t with visibility or the fussy exterior door handles; rather, it’s the car’s overall design. We’d gladly accept a less aerodynamically efficient shape for something more attractive. And no, it doesn’t need to have a traditional sedan shape. But when you apply the EQS hatchback proportions on a smaller sedan, the result—especially in profile and the rear three-quarter views—make it look to us like the rest of the rear end is missing or smushed. We welcome new and exciting designs, whether their underpinnings be electric- or gas-powered. But while the EQE undoubtedly makes a statement, it’s not one most of us appreciate.
That’s too bad, as the 2023 Mercedes EQE350 brings down the cost of a non-SUV electric Mercedes compared to the EQS four-door. The EQE350 lacks the acceleration of the single-spec G80 Electric, but the Mercedes is quick enough and it’s backed by a longstanding brand many trust. But there are too many compromises for us to recommend it the way we did the E-Class two years ago. The 2023 Mercedes EQE350 lacks that car’s dynamic versatility, and at $93,640 as tested, it isn’t a perfect midsize luxury sedan. Still, the E-Class wasn’t perfect out of the box, either. We hope the rest of Mercedes’ EQE lineup improves on the 350’s basics.

source

Sarasota Magazine
1255 N. Gulfstream Avenue, Suite 101, Sarasota, FL 34236
Phone: (941) 487-1100
By Kim Doleatto November 12, 2022 Published in the November-December 2022 issue of Sarasota Magazine
When you’re trying to meet up with friends, numbered addresses and street names can’t compete with local landmarks.
Let’s meet by the red metal horse or the shell fountain. Even without a map, somehow you know where to be. Public art isn’t just eye candy, it’s an anchor.
Sometimes, it’s also a controversy. Like the 25-foot-tall Unconditional Surrender statue by Seward Johnson, based on the famous photo of a U.S. Navy sailor kissing a stranger on V-J Day in Times Square in 1945. Some see it as a joyous nod to the end of World War II, while others see it as a symbol of sexual harassment. On the Sarasota bayfront, it continues to attract thousands of couples each year who, below it, mimic its kissing pose for a pic in paradise.
Public art is also a status symbol. Although, in the past, it wasn’t called “public art,” outdoor décor has been a major part of Sarasota’s appeal ever since real estate developer and circus magnate John Ringling began dressing up boulevards with classical bronze and limestone figures in the 1920s.
No matter how it’s defined, in 1986, the City of Sarasota put a ring on it and made our relationship with public art official when it established the Public Art Committee (PAC). Commissioners were keen to enhance the town’s reputation as an arts city by acquiring works of art for prominent downtown locations. After all, there was a legacy to uphold. During the 1950s and ’60s, a starry group of painters, musicians, architects and writers lived and worked in this flourishing artists’ community. The city purchased several works after the committee formed, including Jack Cartlidge’s large-scale hammered copper sculpture, Nobody’s Listening, for the plaza outside then-new Sarasota City Hall in 1967.
More recently, the city acquired Complexus, a geometric, bright red, steel abstract piece by John Henry. (The sculpture previously stood near the base of the John Ringling Causeway, but, because of construction, is temporarily on loan to the Sarasota Art Museum.) The piece was so beloved that downtown residents and art aficionados rallied to raise the $550,000 to purchase it in just a year’s time. It became part of the city’s public art collection in 2013.
Today, the Office of Public Art has a collection of more than 95 works citywide that has grown beyond sculptures and statues. Murals climb up and across the new walls that bind some downtown streets, adding flair and movement to an otherwise static, high-rise condo-sphere, as with Flora Urbana by artist Danny Doya, the developer’s public art contribution for The Mark condominiums.
Along with the growth spurt Sarasota is seeing, the public art program that once focused on downtown is also growing. Recently, the city expanded it to include areas outside the downtown core. Now, developers of commercial and multifamily residential projects of $1 million or more must dedicate half of 1 percent of the cost, or $5,000 per $1 million, of their projects either toward the purchase of artwork placed at the site or toward the city’s overall public art fund.
Whether purchased or donated, artworks must first be submitted to the PAC to earn a recommendation. The PAC has six members appointed by the City Commission, plus a STAR (Students Taking Active Roles) program member. Members—all volunteers—must have a demonstrated interest in public art. Currently, you’ll find an award-winning local architect and a painter, potter, weaver and glass artist—just to describe a couple—on the PAC. The terms last three years, with a one-time opportunity to be reappointed.
“It’s a smattering of good people,” says Mary Davis Wallace, the head of the city’s public art program since February of last year. “And we want to be sure they are dedicated to advancing the program.”
The time commitment for members “ebbs and flows,” Wallace says, but they have to attend quarterly public art meetings. Outside of that, there’s preparation time to consider. With certain projects that easily garner more than 100 applications, there’s a lot to sift through first.
Residents raised $550,000 to acquire John Henry’s Complexus, which is currently displayed at the Sarasota Art Museum due to construction.
Image: Courtesy City of Sarasota
Although the committee does all that work to settle on its recommendation, the ultimate decision lies with the Sarasota City Commission. PAC recommendations go in front of the commission, which can choose to vote on whether to approve them or not. The overwhelming majority of the time, the recommendation moves forward, but once in a while, it doesn’t.
Following a call to artists issued last year, the city’s PAC recommended the installation of South Korean artist Sujin Lim’s colorful Dwell in the new roundabout located at Fruitville Road and U.S. 41. The resin-cast sculpture was one of three finalists selected from 143 applications submitted by artists around the world. PAC members praised the coral-shaped Dwell for being “playful, colorful and easy to understand.”
But during the city commission’s April meeting, Commissioner Hagen Brody noted, “Coral has no relation to the Gulf coast,” and said that the art “should bear some relation to our region or community.” During the meeting, commissioners could have voted to use one of the other two finalists’ artworks, but instead sent the matter back to the PAC to find three other options.
“I know that the coral experience [the Dwell statue] seemed like the commission said, ‘No,’ but they empowered the Public Art Committee to go back and make a better decision, whereas they could have simply chosen another one they wanted,” says Wallace. “It was respectful. They wanted to put it back in the experts’ corner, and it’s a good opportunity for trying again.” The final outcome of what’s to be installed at the roundabout has yet to be determined.
Striding Liberty, designed by Michael Curtis, was another roundabout art piece city commissioners denied. In 2017, PAC members opted for the classical-style bronze statue depicting a woman with a breastplate, wings, a torch and flowing gown that evoke the Statue of Liberty to be installed at the intersection of North Palm and Cocoanut avenues. But four out of five city commissioners didn’t agree. And neither did the public. At the time, the public voted on the city’s social media platforms, and out of three contenders for the spot, Jumping Fish by Jeffrey Laramore won out. Inspired by coastal living, the blue and orange, contemporary, 16-foot-tall and 12-foot-wide metal statue is hard to miss at the high-profile downtown site.
Although the process for determining public art has changed since 2017 (voting on social media platforms was an isolated experiment at that time), “public input is still built into the process, but currently, our input is mainly through online surveys presented by the city. We always receive emails and welcome opinions,” Wallace says, and she notes they receive a steady influx of those since “there’s lots of sentiment about art.” Public speakers are also welcome to share their opinions in person at city commission public hearings.
Jeff Laramore’s Jumping Fish was inspired by our coast, and took precedence over the Public Art Committee’s first choice, pictured below.
Image: Courtesy City of Sarasota
In the case of developers building new projects (there’s a lot of that happening lately in Sarasota), they can choose to either incorporate a piece of public art in the building process or pay into the city’s public art fund. Another option is to commission a work of public art to be placed elsewhere in the city.
Eric Fenton, vice president of development for the national firm Belpointe, went with the first option, “because it’s more fun and we take a personal interest,” he says. “We selected a nationally recognized artist from the D.C. area, Zack Oxman. He’s going to provide a concept and we’ll likely have some 3D renderings to present soon to see how it looks from all sides. I collaborated with him before on a public art installation outside of a residential development in the D.C. area and he’s incredibly talented.”
The piece will be part of the massive site on the corner of Links Avenue and Main Street, which is slated for completion in roughly 18 months and will feature 50,000 square feet of retail space on the bottom floor. Located at 1991 Main St., the official name of the project will be announced later in the year.
As for its public art component, per the mandatory developer’s checklist for creating a public art piece, “it will be visible from Main Street and interact with the public realm,” Fenton says. “We’ve just kicked off with the concept phase, so I don’t have any firm details on dimensions, but it will be something sizeable and eye-catching.” The project will be comprised of two 10-story buildings with 424 multifamily units on roughly five acres, and will be the largest rental project to open downtown in years.
After more than 15 years in the industry, Fenton says including a public art component in development projects is becoming more common, “especially in cities that celebrate the arts and consider themselves cultural centers. In response, I think a lot of developers are supportive because it benefits everyone.”
When a developer chooses to eschew the public art component and pay into the public art fund instead, those funds are used for acquiring other works, but also for things like the maintenance of older ones. Recently, The Butterfly Lady by Auguste Moreau was restored by Jon Dowd and Wayne Dyer from Bronzart, who removed and replaced the artwork in order to clean, wax and add a patina to the beloved piece. In collaboration with the city’s Sculpture on Loan program, the whimsical winged statue currently resides and shines at Florida Studio Theatre on the corner of Cocoanut and North Palm avenues.
Nobody’s Listening, by Jack Cartlidge, stands at Sarasota’s City Hall and has been part of the city’s art collection since 1967.
Image: Courtesy City of Sarasota
Then there’s public art that’s been privately funded and has no link to the PAC or its processes, like the recent murals throughout the Rosemary District, just north of downtown Sarasota. Many of these colorful murals, each painted by a different artist, aim to honor the past legacy of the historically Black neighborhood, which is growing into a major condo hub thanks to its prime location. In historic Burns Court, an Avenue of Art brightens the sidewalk tiles with depictions of everything from baseball players to beach scenes.
However Sarasota’s outdoor art gallery grows, it’s for everyone to experience. The free Otocast audio tour app provides users with a map of some of Sarasota’s most celebrated public art pieces. Kicking off with a brief audio introduction by Wallace, each piece is accompanied by a voice recording from the artist, who takes a minute or two to explain the process and inspiration behind his or her creation.
Thanks to recent funding, plans are in the works to expand the app to include the city’s entire public art collection, hovering now around 100. The collection will be the foundation of a new public art master plan Wallace will present to the city commission in January 2023.
In it, “we’re starting to look at other types of art,” Wallace says. “There will be interactive art people can touch and engage with. There will be pressing concrete with poems and painting on sidewalks like in Burns Court. There’s going to be more discovery in our public art program to activate more areas, and also cross-collaboration with the city’s historic preservation and sustainability staff.”
Initial recommendations include working with Ringling College of Art and Design students to create projected art and collaborating with Sarasota County to place public art on city trailheads and crossings. Another proposal is to decorate city and neighborhood gateways with public art, and increasing access to all artworks by installing braille signage, among other efforts to make pieces more accessible.
The finer details will be determined case by case. The master plan will merely provide a larger framework. “You want it to be loose enough so we’re able to flex in times of prosperity or recession, without committing to anything hard,” Wallace says. “That’s the grace of a master plan.”

source

Sarasota Magazine
1255 N. Gulfstream Avenue, Suite 101, Sarasota, FL 34236
Phone: (941) 487-1100
By Kay Kipling November 12, 2022 Published in the November-December 2022 issue of Sarasota Magazine
At the lovely, secluded beachside spot on Manasota Key that is the Hermitage Artist Retreat, seabirds wheel, waves splash and white sand makes for peaceful strolls. It’s a haven for artists lucky enough to receive a residency there, and it’s also a place where locals can attend talks, performances and other events featuring those artists—often at little or no cost.
Things weren’t so peaceful on the campus in September, when Hurricane Ian struck the Hermitage and devastated much of the Englewood community. While most of the buildings on the campus remained standing after the storm, the hurricane caused significant damage to the property, and repairs are expected to cost more than $1 million.
That news reverberated far beyond Sarasota County’s beaches. Since the Hermitage’s founding about 20 years ago as a place where individual artists have the time and freedom to create, more than 600 makers of music, dance, theater, literature and visual art have found inspiration there. And the work they have done at the retreat has gone on to stages and museums around the world.
Flutist Claire Chase
Image: Courtesy Photo
Just a few examples: Playwrights Bess Wohl (Grand Horizons), Michael R. Jackson (A Strange Loop, White Girl in Danger) and Paula Vogel (How I Learned to Drive, The Mother Play); screenwriter Roberto Bentivegna (House of Gucci); composer Vijay Iyer (Bruits); flutist Claire Chase (Density 2036); and visual artists Trenton Doyle Hancock and Sanford Biggers are just a handful of the professionals who spent some of the most productive times of their careers at the Hermitage. (A quick peek at the Hermitage website reveals many more highly acclaimed names over the decades.)
Image: Nancy Guth
Hermitage chief executive officer and artistic director Andy Sandberg, who has worked at the Hermitage since 2019, says the retreat typically hosts between 75 and 80 artists a year for varying lengths of time, adding up to four weeks each over two years. On average, five or six artists occupy the Old Florida historic cottages and homes of the site at any one time.
“It’s such a life-changing experience for them,” Sandberg says. “We need to tell their stories better. People see our programs here, but the work created here goes on to [be enjoyed by] hundreds and thousands, if not millions, of others.”
In order to tell those stories, the Hermitage is hiring a full-time alumni coordinator to add to a staff that has already blossomed in the past couple of years, with seven other employees besides Sandberg.
The journeys the artists embark on at the Hermitage “are quite epic,” Sandberg says. “Sometimes, the work doesn’t come to fruition for years.” But in the meantime, “they are part of our family and ambassadors to the world.”
Sandberg says the Hermitage experience is a “chance for an artist to try something out, sometimes for the first time, or in a new format.” Sometimes, it’s just easier to create in Sarasota than, say, New York or London.
Bess Wohl, for example, was unable to rehearse her new show, Camp Siegfried, elsewhere during the worst of the Covid-19 pandemic. But here, the Hermitage connected her with actors from Florida Studio Theatre with whom she was able to rehearse and workshop the show—which is now included in the upcoming season of New York’s Second Stage Theater.
Sandberg admits that some of the artists “have never heard of Sarasota” before they come here. “But they leave singing the song of Sarasota,” he says, especially after they collaborate with arts groups here. “There are a few hundred untold stories we don’t even know ourselves,” he adds.
Tony Award winner Gavin Creel
Image: Courtesy Photo
One such story comes from Tony Award winner Gavin Creel (Hello Dolly!, Hair and, most recently, the revival of Into the Woods on Broadway). Creel was at the Hermitage to workshop and develop the original musical piece Walk on Through, a commission from the Metropolitan Museum of Art. This set the groundwork for Creel to get the piece to the next level at the Eugene O’Neill Festival, where, he says, “we tore it apart and built it back up.” He’s now ready for that piece to move on to a backers’ audition in New York City.
“It couldn’t have been ready [for that] without the Hermitage,” Creel says. But he spent the first of three weeks here last January, and says the place gave him “time, space and quiet” to work.
“When I’m in motion is when my ideas come in,” he says. “At the Hermitage, I walked five to nine miles every day on the beach in my bathing suit. The Hermitage gave me an unbelievable launching pad and permission to take risks.”
Jeanine Tesori
Image: Courtesy Photo
For composer Jeanine Tesori (Thoroughly Modern Millie, Fun Home), her stay at the Hermitage came when she was feeling blocked. “I hadn’t been able to write for weeks,” she says. “I was panicked and late with a deadline.” Then, “between the welcoming spirit of Andy and the staff, the community, the soothing sounds of the waves, I was finally able to put notes down.”
Tesori not only wrote a major portion of the second act for a musical version of George Brant’s play Grounded (due to premiere at Washington National Opera in 2023, before a production at the Met in 2025), she also wrote the end of the first act to the current Broadway musical Kimberly Akimbo while at the Hermitage. “It was a pivotal time for me, as I hear it has been for all artists who are lucky enough to spend time there,” she says.
James Whiteside
Image: Courtesy Photo
American Ballet Theater dancer and choreographer James Whiteside spent two weeks at the Hermitage adapting his autobiographical book Center Center for the stage. “My time there was so productive, I ended up with drafts of two different plays,” he says. “Every morning I woke up, made coffee and started writing. I’d take a break to take a dip in the ocean and make meals, then I’d get right back to work. There were no distractions, and it was the perfect place to let the creative juices flow.” Besides all that, Whiteside was also able to take a ballet class every other day in a dance studio set up by the Hermitage staff. One version of Center Center, a solo dance piece, is intended for performance at Theatre Aspen soon.
“I can’t think of a better place to work on what I’m doing,” says visual artist Amanda Williams, who worked on preparatory sketches for the next iteration of her series What Black Is This, You Say? while in Englewood. The series began in 2020 during the pandemic lockdown as a response to media strategies raising awareness around racial injustice, such as Blackout Tuesday. Watercolors were a small, fast medium used as “placeholders” until Williams could return to the studio. A large-scale version of Williams’ project will be exhibited as part of Art Basel Miami Beach with Rhona Hoffman Gallery.
Williams was also impressed with the Hermitage’s Family Residency program, which provides babysitters for artists’ children during their stay. As a mother of young children, Williams thought residencies would never work for her. “For me, it was invaluable to have my family with me,” she says. “They had complete comfort here. That would be so much harder back in Chicago.”
“I think a lot of artists come, and here they unlock new ideas and possibilities,” says Sandberg. “Sometimes they do the work they came here to do really quickly, and then open their minds to start something new,” often with a multidisciplinary hybrid approach. “We’re the only major arts organization here devoted to creating new work, and we’re shining an international light.”

source

NEW YORK, Nov. 10, 2022 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Equillium, Inc. EQ's merger with Metacrine Inc. If you are an Equillium shareholder, click here to learn more about your rights and options.  
Sitio Royalties Corp. STR's merger with Brigham Minerals, Inc. Under the terms of the merger agreement, Sitio's shareholders will receive one share of common stock in the combined company for each share of Sitio common stock owned on the closing date. Upon completion of the transaction, Sitio shareholders will own approximately 54.0% of the combined entity on a fully diluted basis. If you are a Sitio shareholder, click here to learn more about your rights and options.  
Brigham Minerals, Inc. MNRL's merger with Sitio Royalties Corp. Under the terms of the merger agreement, Brigham shareholders will receive a fixed exchange ratio of 1.133 shares of common stock in the combined company for each share of Brigham common stock owned on the closing date. Upon completion of the transaction, Brigham shareholders will own approximately 46.0% of the combined entity on a fully diluted basis. If you are a Brigham shareholder, click here to learn more about your rights and options.
STORE Capital Corporation STOR's sale to GIC and funds managed by Oak Street for $32.25 per share in cash. If you are a STORE Capital shareholder, click here to learn more about your rights and options.  
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected] 
https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-eq-str-mnrl-stor-301674562.html
SOURCE Halper Sadeh LLP
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

source

FOX31 Denver
Please enter a search term.
Please enter a search term.
by: Talya Cunningham
Posted: Nov 10, 2022 / 11:11 PM MST
Updated: Nov 10, 2022 / 11:11 PM MST
by: Talya Cunningham
Posted: Nov 10, 2022 / 11:11 PM MST
Updated: Nov 10, 2022 / 11:11 PM MST
DENVER (KDVR) — Hip hop royalty set foot in Denver on Thursday night. Legendary rapper Master P was not using his words for lyrics — instead, he was using his words to educate Coloradans about mental health struggles in the Black community.
The 1990s entertainer took the microphone with a different flow to share his story and inspire young people and his own culture. Music is just one of Master P’s many talents; he is also an actor, father, producer, athlete and entrepreneur who is using his life experiences to lift up the Black community and shine light on some dark issues.
To the music industry he is Master P, but on Thursday night at New Hope Baptist Church, he is Percy Miller.
“It takes a village, and that village is us coming together,” Miller said.
Miller was a guest speaker at the Extraordinary Speaker series hosted by Colorado branches of the NAACP. The civil rights organizations are joining forces to discuss the Black community’s experiences with mental health, education, economic inequality and environmental justice.
According to an official release, the NAACP Extraordinary Speakers Series began Thursday, Oct. 27, with a presentation on “Understanding the Blue Book.” The series goes until Thursday, Nov. 17, and includes virtual sessions on environmental justice with the Denver NAACP Environmental justice committee (Nov. 3) and “Talking About Race with Children” with Dr. Darlene Sampson and Dr. Rosemarie Allen (Nov. 17).
On Thursday evening, people of all ages packed the pews at New Hope Baptist Church for the event, which started with testimonials from NAACP representatives discussing generational trauma and mental illness, followed by words from Denver Mayor Michael Hancock.
“As a Black community we often say, ‘Baby, pray about it,’” Hancock said. “But we also know that faith without works is dead. We’ve got people and almost everyone in this room has some form of mental health challenge in our family, and we as a community have got to rise up.”
After his remarks, the mayor gave a warm welcome to Miller, who took the stage as the crowd cheered with applause. The entertainer discussed tackling Black mental health, something that is still a stigma in the African American community and not widely discussed.
“We don’t talk about it as Black people, we try to hide it because we feel like it’s a problem that makes us weak and it makes us vulnerable,” Miller said. “We’re losing so many lives; we’re losing so many people.”
Miller spoke from his heart and his own personal experiences. Miller’s daughter suffered from mental illness and this past May, she died from an accidental fentanyl overdose at just 29 years old. Outliving his daughter has fueled Miller’s fire in the fight, and it’s something Colorado is fighting itself. Fentanyl overdoses across the state and country have skyrocketed.
“We taking fentanyl,” Miller said. “We doing all kinds of things. We thinking this is not going to kill us. Self-medication isn’t the answer.”
Miller preached to young kids that instead of turning to substances to cope, try opening up the lines of communication and asking for help. The entertainer shared personal stories and had a hard life himself, saying he didn’t have a bed until he was in college. He said faith got him through his struggles and now he’s devoted to helping and guiding others with goals of stopping the mental health stigma and teaching economic empowerment.
“I pray for wisdom,” Miller said. “I don’t pray for money; money comes and goes. We can’t take it with us. Mental illness and substance abuse is real. How we make those changes and how we live is going to start with you.”
Submit
Δ
Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Thanks for signing up!
Watch for us in your inbox.
Subscribe Now
Thanks for signing up!
Watch for us in your inbox.
Subscribe Now

source

The best budget headphones.  ·  Source:
Headphones are a discrete and affordable solution for working on the go, and they’re essential for monitoring while tracking. We’ve selected some of the best budget headphones for music production and we’ll discuss some features to help you choose the right pair of cans.
Headphones are built with different designs, so it’s important to know some of the basic terminologies to ensure you pick the right type for your specific purpose:
If you’re looking for a decent affordable option, the SRH240 is a closed-back pair of headphones that offers good isolation. This makes them useful for monitoring while tracking and you’ll be able to easily work discretely.
The low impedance rating of 38 ohms means the SRH240 will perform well on a wide range of devices including consumer devices without an integrated headphone preamplifier.
Downsides? Well, the 2-meter lead is perhaps not the greatest design, but these are still great-value headphones for the price.
Shure SRH240
Shure SRH240
The MDR-7506 has been the industry standard in film, TV, broadcast, and music studios for decades in the US and many other countries too. They’re comfortable, well-built, and offer decent isolation.
In addition, they reach low enough to deal with the frequency range found in today’s more sub-heavy music styles. So whether you use them for recording or mixing, the 7506 will prove equal to the task.
One weak point, however, is the coating on the earpads tends to flake off after years of frequent use. So to avoid this, you can replace the pads with more durable ones from Dekoni.
Sony MDR-7506
Sony MDR-7506
The popular ATH-M40x is another excellent closed-back design with great build quality for the price. They might not be the best-sounding pair of headphones ever, but as long as you reference back and forth with your monitors, you should be OK.
They do, however, provide an excellent and long-lasting solution for discrete monitoring while tracking vocals or instruments. This is precisely why many studios have batches of them in the equipment locker.
With an impedance rating of 35 ohms, the ATH-M40x is also suitable for consumer devices and is also widely used by DJs.

Audio-Technica ATH-M40X
The classic K240 has been part of the furniture in studios since its introduction in 1975. The comfortable semi-open design makes them a great choice for mixing and editing at home or while traveling.
As a package, the K240 MKII ships with both coiled and straight cables, plus an additional set of velour earpads for additional comfort during extended hours in use.
The detail and relative neutrality you get from these headphones are the reason many producers and engineers swear by them – a great value set of cans.
AKG K240 MKII
AKG K-240 MKII
It would be impossible not to have Beyerdynamic in the conversation; after all, they did invent dynamic headphones back in 1937!  The DT 990 Pro is an open-back design that offers reduced ear fatigue, making it the better choice for mixing,
Being open-back headphones, the isolation properties aren’t the greatest so they’re not ideal for recording purposes. In addition, the 250 Ohms impedance rating means they will perform optimally with devices that offer preamplification.
You can find decent headphones preamps on some desktop mixers, audio interfaces, and monitor controllers, so be sure to get something portable if you plan on using the DT 990 Pro on the go.
Beyerdynamic DT 990 Pro
beyerdynamic DT-990 Pro
After taking a quick poll around the Gearnews team, we found that most of us had at least one pair of AKG K240s lying around! but what are your favourite budget headphones? Do you have a favourite pair of headphones you’d like to share with our readers?
Please let us know in the comments below!
Videos:
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Load video
Always unblock YouTube
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Load video
Always unblock YouTube
* Note: This article contains promotional links that help us fund our site. Don’t worry: the price for you always stays the same! If you buy something through these links, we will receive a small commission. Thank you for your support!
How do you like this post?
Gotta say it’s weird as heck not having Slate VSX on this list.
Thanks for the suggestion, but at close to $500, the Slate VSX is far from being a budget set of headphones.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website

13 Nov · Thanks for the suggestion, but at close to $500, the Slate VSX is far from being a budget set of headphones.
13 Nov · Gotta say it’s weird as heck not having Slate VSX on this list.
13 Nov · Ahh, love the Prodigy so thank you for putting this together 🙂

source

Grady Owens (L), Jason Owens (C-R)
A 50-year-old father and his 22-year-old son from Blanco, Texas entered guilty pleas on Thursday, admitting they joined the pro-Trump mob on Jan. 6 and assaulted cops.
Jason Douglas Owens and his son Grady Douglas Owens, arrested in April 2021, each pleaded guilty to a count for assaulting, resisting, or impeding a law enforcement officer, felonies for which they could face up to 8 years in prison, according to the Department of Justice. Grady Owens additionally pleaded guilty to misdemeanor disorderly conduct.
The statement of offense for Grady Owens, which the defendant admitted is an accurate accounting of his actions, stated that he attacked Metropolitan Police Officer C.B., hitting the side of the cop’s body with a skateboard.
“According to court documents, on Jan. 6, 2021, both defendants illegally entered the Capitol grounds. At about 2 p.m., they were in the west lawn area. A group of officers walked through the crowd of rioters, on their way to the Lower West Terrace. As the officers walked by, Grady Owens turned, raised a skateboard in the air, and struck an officer on the side of his body. A skirmish then erupted between other officers and rioters, resulting in additional assaults by others of officers,” the DOJ said in a press release.
As other pro-Trump rioters began attacking police, Jason Owens joined the fray and “shoved” MPD Officer N.D. “hard enough to cause his head to snap back,” according to his statement of offense.
The father-son duo pointed and yelled at the cops after committing the assaults, court documents said. That was before they joined the mob that “attempted to push their way into the East Rotunda Doors without success,” DOJ said. Jason Owens attacked another cop M.B., and fought over his baton.
Authorities noted that Jason Owens denied committing any violence when he was initially interviewed by the feds.
Grady Owens’ plea agreement estimates a sentencing guidelines range of 37 to 46 months, or just over 3 and nearly 4 years behind bars. On Jan. 6, he recorded himself saying “We will not concede,” and “You can’t stop us.”
According to the feds, Grady Owens’ Instagram photo proved an effective way to confirm his identity.
An FBI special agent “conducted a review of Instagram User grady_owens_ Instagram account, which is open to public viewing, and noted the user was involved with Music Production courses of study at Full Sail University,” the affidavit in his case said.
From there, the special agent met in March 2021 with a university employee who confirmed that the Instagram photo showed Owens. The same witness looked at an image featured in a @SeditionHunters tweet and “immediately” identified Owens despite there being “[n]o identifiable information[…] present on the photograph shown.”
Jason Owens’ estimated guidelines range is 24 to 30 months, or 2 to 2.5 years in prison.
Another @SeditionHunters photo played a role in his downfall and capture as well, documents show. The elder Owens, pictured below inside a red oval, was caught in the image putting his hands on cops. His son was right behind him at the time.
Sedition Hunters image of Jason Owens
Sentencing for the defendants is set for Feb. 24, 2023.
[Images via DOJ]
Have a tip we should know? [email protected]
Matt Naham is the editor-in-chief of Law&Crime.
Have a tip or story idea? Email us. Or to keep it anonymous, click here.

source

PARAMOUNT+ ANNOUNCES ALL-NEW EPISODES OF “BEHIND THE MUSIC” TO PREMIERE TUESDAY, NOV. 29
New Episodes of the Groundbreaking Documentary Series, Produced by MTV Entertainment Studios, to Feature Jennifer Lopez, Boy George, Remy Ma and More
Official Trailer and Key Art Released


Nov. 11, 2022 – Paramount+ today announced new episodes of the groundbreaking documentary series BEHIND THE MUSIC will premiere exclusively on the service in the U.S. and Canada on Tuesday, Nov. 29, featuring Jennifer Lopez, Boy George, Jason Aldean and Remy Ma. Additionally, seven remastered episodes spotlighting iconic artists Boyz II Men, Christina Aguilera, Gloria Estefan, Hootie & the Blowfish, Mötley Crüe, Pink and TLC will drop the same day. Paramount+ also released an official trailer and key art for the series. The episodes will drop in additional international markets where the service is available throughout 2022-2023.
Official loglines for new episodes:

· After three decades, Jennifer Lopez is at the very top of her game and shows no signs of slowing down. J.Lo reflects on key moments of her iconic career in music, film and fashion while celebrating her present with husband Ben Affleck.

· Boy George reflects on his meteoric rise from outcast to ’80s global superstar with Culture Club. A tumultuous love affair, intense fame and addiction almost destroyed his career – but 40 years on, he remains an LGBTQ+ pop icon.

· Jason Aldean is a small-town kid turned country superstar who never backed down in life, and changed the country music genre forever.

· Remy Ma shares her journey to becoming the queen of New York hip hop. Her road to fame with the Terror Squad was paved with loss – a prison sentence almost ended it all – but her comeback inspired millions.
These four artists join the star-studded lineup of original BEHIND THE MUSIC episodes on Paramount+ featuring Bret Michaels, Busta Rhymes, Duran Duran, Fat Joe, Huey Lewis, LL Cool J, New Kids on the Block and Ricky Martin.
The series is executive produced by Bruce Gillmer, Jennifer Demme and Michael Maniaci for MTV Entertainment Studios. Mark Ford and Alex Castino executive produce for Creature Films, alongside Tara Long for Entertainment One.
About Paramount+
Paramount+ combines live sports, breaking news and a mountain of entertainment. The premium streaming service features an expansive library of original series, hit shows and popular movies across every genre from world-renowned brands and production studios, including BET, CBS, Comedy Central, MTV, Nickelodeon, Paramount Pictures and the Smithsonian Channel. The service is also the streaming home to unmatched sports programming, including every CBS Sports event, from golf to football to basketball and more, plus exclusive streaming rights for major sports properties, including some of the world’s biggest and most popular soccer leagues. Paramount+ also enables subscribers to stream local CBS stations live across the U.S. in addition to the ability to stream other live channels: CBSN for 24/7 news, CBS Sports HQ for sports news and analysis and ET Live for entertainment coverage. For more information about Paramount+, please visit www.paramountplus.com and follow @ParamountPlus on all social platforms.
About Paramount Media Networks & MTV Entertainment Studios
Paramount Media Networks & MTV Entertainment Studios is one of the preeminent media entities in the world that connects with global audiences through its nine iconic brands – MTV, Comedy Central, VH1, CMT, Pop, Logo, The Smithsonian Channel, Paramount Network and TV Land – and its Studios arm which produces acclaimed series and movies as well as award-winning documentaries through MTV Documentary Films.
About Creature Films
Creature Films is a full-service film and television production company and a leading producer of premium documentary content. The company is owned and run by Mark Ford. Creature has produced over a hundred hours of programming, with credits that include MTV’s “Siesta Key” and “Laguna Beach”; Paramount’s Emmy(R)-nominated “Behind The Music”, Amazon’s “Mary J Blige’s My Life”; and A&E’s Emmy(R)-nominated “L.A. Burning: The Riots 25 Years Later”, “Streets of Compton” and “Biggie: The Life of Notorious B.I.G.”
About Entertainment One
Entertainment One Ltd. (eOne) is a talent-driven independent studio that specializes in the development, acquisition, production, financing, distribution and sales of entertainment content. As part of global play and entertainment company Hasbro (NASDAQ: HAS), eOne’s expertise spans across film, television and music production and sales; family programming, merchandising and licensing; digital content; and live entertainment. Through its extensive reach and scale, and a deep commitment to high-quality entertainment, eOne unlocks the power and value of creativity.
eOne brings to market both original and existing content, sourcing IP from Hasbro’s portfolio of 1500+ brands, and through a diversified network of creative partners and eOne companies.

source

Liz Truss resignation: Tory PM hopefuls need backing of 100 MPs by Monday to enter race  BBC
source

Post-hoc analysis of DISCOVER-2 Phase 3 data suggest active psoriatic arthritis patients with week 8 response to TREMFYA showed meaningful improvements in health-related quality of life at week 100, compared to patients without early response
Additional post-hoc analyses show treatment with TREMFYA demonstrated improvements of fatigue (FACIT-F scale) at week 8, demonstrating clinically meaningful and durable long-term improvements, with nearly a third maintaining normative levels through week 100
SPRING HOUSE, Pa., Nov. 10, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new post-hoc analysis of the Phase 3 DISCOVER-2 study that show early (week 8) clinical improvements^a of most measures (joint and skin disease, enthesitis and dactylitis) in adult patients with active psoriatic arthritis (PsA) treated with TREMFYA^® (guselkumab) were associated with meaningful improvements in health-related quality of life (HRQoL) (measured by EQ-5D)^b from year one (week 52) through year two (week 100).¹ TREMFYA is the first fully human selective interleukin (IL)-23 inhibitor therapy approved in the U.S. for adults with active PsA and adults with moderate to severe plaque psoriasis (PsO).²
People with active PsA can experience both physical and mental health challenges that can interfere with their daily lives and impact their work and relationships. Additionally, some patients experience fatigue – a burdensome symptom that often can be underestimated and underreported.³
In a separate post-hoc analysis of DISCOVER-2, clinically meaningful improvements in fatigue (measured by Functional Assessment of Chronic Illness Therapy-Fatigue [FACIT-F])^c observed at one year in TREMFYA-treated patients were enhanced through two years, resulting in greater proportions of patients achieving normative FACIT-F levels.⁴
“Patients with active psoriatic arthritis may struggle with engaging in everyday tasks as a result of health-related quality of life symptoms often associated with the disease,” said Philip J. Mease, M.D.,^d Swedish Medical Center/Providence St. Joseph Health and University of Washington in Seattle, Washington. “In these analyses, we see that achieving early clinical strides in distinct symptom domains may demonstrate future gains in health-related quality of life and fatigue improvement, which underscores the important role this therapy plays in the management of the multiple and complex symptoms of active psoriatic arthritis.”
These new analyses of DISCOVER-2 data presented at the 2022 American College of Rheumatology (ACR) Convergence meeting, taking place in Philadelphia, PA and virtually, November 10-14, 2022, show:
Improvements in Health-Related Quality of Life Through Two Years
In DISCOVER-2, biologic-naïve patients with active PsA who were randomized to TREMFYA:¹
Early (week 8) response in distinct active PsA domains differentially impacted specific components of HRQoL (e.g. EQ-5D, SF-36, DLQI)^b,e over two years versus placebo.
Statistically significant improvements in overall and physical HRQoL were observed among early clinical responders across several active PsA domains including joint and skin disease, enthesitis, and dactylitis, versus placebo.
Despite differences in HRQoL observed among early clinical responders and non-early responders, non-early responders also saw benefit in long-term HRQoL with TREMFYA versus placebo.
Clinically Meaningful Improvements in Fatigue Through Two Years
In DISCOVER-2 patients with active PsA and elevated measures of fatigue:⁴
TREMFYA provided statistically significant benefit over placebo for reducing fatigue as early as week 8 (nominal P-values).
FACIT-F scores continued to improve between week 24 and week 52 in TREMFYA-treated patient groups.
The clinically meaningful improvements in fatigue seen at week 52 in TREMFYA-treated patients were further enhanced through week 100, resulting in greater proportions of patients achieving normative FACIT-F levels.
Improvement of ≥2 points in FACIT-F by week 8 predicted clinically meaningful improvement of ≥4 points at week 100.
Early targets in FACIT-F levels achieved at 8 weeks of TREMFYA treatment were identified as a potential predictor of later response.
“The burden of active psoriatic arthritis on a patient’s quality of life makes the task of effectively managing the debilitating symptoms of this disease all the more urgent and challenging,” said Terence Rooney, M.D., Vice President, Rheumatology and Maternal-Fetal Immunology Disease Area Leader, Janssen Research & Development, LLC. “These analyses from DISCOVER-2 provide patients and physicians with critical insights as they consider the most appropriate treatment option to manage physical symptoms and help improve overall well-being.”  
Editor’s Notes: 
a.  Early (week 8) clinical improvement was defined as any of the following:
≥20% improvement in swollen joint count (SJC), tender joint count (TJC), patient pain visual analogue scale (VAS), patient Skin VAS, Health Assessment Questionnaire-Disability Index (HAQ-DI)
≥4-point improvement in FACIT-F measure¹
Minimal clinically important improvement in clinical Disease Activity in PsA (cDAPSA, ≥5.7) composite score¹
Change (reduction) in the Leeds enthesitis index (LEI) or dactylitis severity score (DSS)¹
b.  EQ-5D is a preference-based HRQoL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort and anxiety/depression.⁵
c.  FACIT-F Scale: measured on a 4-point Likert scale (4 = not at all fatigued to 0 = very much fatigued).⁶
d.  Dr. Mease is a paid consultant for Janssen. He has not been compensated for any media work.
e.  Dermatology Life Quality Index (DLQI) is a self-administered questionnaire for patients to score the impact of PsO on their quality of life. The higher the score, the more quality of life is affected. Scores may range from 0-1, indicating no effect of PsO on a patient’s life, to 21-30, indicating many aspects of their life are severely affected by PsO.⁷
f.  The PASI score grades the combination of the amount of surface area covered by PsO plaques in each body region, and the degree of plaque redness, thickness, and scaliness to assess the extent and severity of PsO.⁸
About DISCOVER-2 (NCT03158285)⁹
DISCOVER-2 is a randomized, double-blind, multicenter Phase 3 study evaluating the efficacy and safety of TREMFYA administered by SC injection in biologic-naïve patients with active PsA. DISCOVER-2 evaluated 739 participants who were treated and followed through approximately two years. The study consisted of a screening phase of up to six weeks, a blinded treatment phase of approximately 100 weeks that included a placebo-controlled period from week 0 to week 24 and a blinded active treatment period from week 24 to week 100. It also included a safety follow-up phase through week 112 (i.e., approximately 12 weeks after the last administration of study agent at week 100). Clinical efficacy, radiographic efficacy, health economics, safety, pharmacokinetics, immunogenicity, biomarker, and pharmacogenomics evaluations were performed in the study on a defined schedule.¹⁰
About Psoriatic Arthritis (PsA)
PsA is a chronic, immune-mediated inflammatory disease characterized by peripheral joint inflammation, enthesitis (pain where the bone, tendon and ligament meet), dactylitis (a type of inflammation in the fingers and toes that can result in a swollen, sausage-like appearance), axial disease, and the skin lesions associated with plaque PsO.^11-13 The disease causes pain, stiffness and swelling in and around the joints; it commonly appears between the ages of 30 and 50, but can develop at any age.¹⁴ Nearly half of patients with PsA experience moderate fatigue and about 30 percent suffer from severe fatigue as measured by the modified fatigue severity scale.¹⁴ In patients with PsA, comorbidities, such as obesity, cardiovascular diseases, anxiety and depression are often present.¹⁵ Studies show up to 30 percent of people with plaque PsO also develop PsA.¹⁶ Although the exact cause of PsA is unknown, genes, the immune system and environmental factors are all believed to play a role in disease onset.¹⁷
About TREMFYA^® (guselkumab)¹
Developed by Janssen, TREMFYA is the first approved fully human monoclonal antibody that selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23 receptor. IL-23 is an important driver of the pathogenesis of inflammatory diseases such as moderate to severe plaque PsO and active PsA. TREMFYA is approved in the U.S., Canada, Japan, and a number of other countries worldwide for the treatment of adults with moderate to severe plaque PsO who are candidates for injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light), and for the treatment of adult patients with active PsA. It is also approved in the EU for the treatment of moderate to severe plaque PsO in adults who are candidates for systemic therapy and for the treatment of active PsA in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug therapy.
The Janssen Pharmaceutical Companies of Johnson & Johnson maintain exclusive worldwide marketing rights to TREMFYA^®.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about TREMFYA^®? TREMFYA^® is a prescription medicine that may cause serious side effects, including:
Serious Allergic Reactions. Stop using TREMFYA^® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
Infections. TREMFYA^® may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA^® and may treat you for TB before you begin treatment with TREMFYA^® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA^®.

Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
Do not take TREMFYA^® if you have had a serious allergic reaction to guselkumab or any of the ingredients in TREMFYA^®.
Before using TREMFYA^®, tell your healthcare provider about all of your medical conditions, including if you:
have any of the conditions or symptoms listed in the section “What is the most important information I should know about TREMFYA^®?”
have an infection that does not go away or that keeps coming back.
have TB or have been in close contact with someone with TB.
have recently received or are scheduled to receive an immunization (vaccine). You should avoid receiving live vaccines during treatment with TREMFYA^®.
are pregnant or plan to become pregnant. It is not known if TREMFYA^® can harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if TREMFYA^® passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TREMFYA^®? TREMFYA^® may cause serious side effects. See “What is the most important information I should know about TREMFYA^®?”
The most common side effects of TREMFYA^® include: upper respiratory infections, headache, injection site reactions, joint pain (arthralgia), diarrhea, stomach flu (gastroenteritis), fungal skin infections, herpes simplex infections, and bronchitis.
These are not all the possible side effects of TREMFYA^®. Call your doctor for medical advice about side effects.
Use TREMFYA^® exactly as your healthcare provider tells you to use it.
Please read the full Prescribing Information, including Medication Guide for TREMFYA^®, and discuss any questions that you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-82626v3
About the Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism, & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.
Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenGlobal and www.twitter.com/JanssenUS.
Janssen Research & Development, LLC; Janssen Biotech, Inc.; and Janssen Scientific Affairs, LLC are part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding TREMFYA^® (guselkumab) product development. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Janssen Research & Development, LLC, any of the other Janssen Pharmaceutical Companies and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behavior and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2022, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. None of the Janssen Pharmaceutical Companies nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.
References
McInnes I, et al. Early Clinical Improvement as Predictor of Long-term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated with Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study. Presented at ACR Convergence 2022, Nov. 10-14. Accessed October 2022.
TREMFYA^® Prescribing Information. Available at: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/TREMFYA-pi.pdf. Accessed October 2022.
Creaky Joints. Psoriatic Arthritis and Mental Health: The Link to Depression, Anxiety, Fatigue, and More. Available at: https://creakyjoints.org/about-arthritis/psoriatic-arthritis/psa-treatment/psoriatic-arthritis-mental-health/. Accessed October 2022.
Gladman D, et al. Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis. Presented at ACR Convergence 2022, Nov. 10-14. Accessed October 2022.
EuroQol Research Foundation. EQ-5D-5L User Guide 2021. September 2019. Available at: https://euroqol.org/wp-content/uploads/2021/01/EQ-5D-5LUserguide-08-0421.pdf.
Acaster S, et al. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia Health Qual Life Outcomes. 2015; 13: 60.
Finlay AY and Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3):210-216.
Feldman SR and Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005;64(Suppl II):ii65-ii68.
ClinicalTrials.gov. A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis. Identifier: NCT03158285. Available at: https://clinicaltrials.gov/ct2/show/NCT03158285.
Mease, P., et al Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. The Lancet, 2020:395(10230), 1126–1136. https://doi.org/10.1016/s0140-6736(20)30263-4
Belasco, J., & Wei, N. Psoriatic Arthritis: What is Happening at the Joint? Rheumatology and Therapy, 2019:6(3),305–315. https://doi.org/10.1007/s40744-019-0159-1
Donvito T. CreakyJoints: What Is Enthesitis? The Painful Arthritis Symptom You Should Know About. Available at: https://creakyjoints.org/symptoms/what-is-enthesitis/. Accessed January 2022.
Donvito T. CreakyJoints: What Is Dactylitis? The ‘Sausage Finger’ Swelling You Should Know About. Available at: https://creakyjoints.org/symptoms/what-is-dactylitis/. Accessed January 2022.
Husted, J. A., et al. Occurrence and correlates of fatigue in psoriatic arthritis. Annals of the Rheumatic Diseases, 2008:68(10), 1553–1558. https://doi.org/10.1136/ard.2008.098202
Haddad A and Zisman D. Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J. 2017;8(1):e0004.
National Psoriasis Foundation. About Psoriatic Arthritis. Available at: https://www.psoriasis.org/about-psoriatic-arthritis/. Accessed January 2022.
Cassell, S., & Kavanaugh, A. Psoriatic arthritis: Pathogenesis and novel immunomodulatory approaches to treatment. Journal of Immune Based Therapies and Vaccines. 2005;3:6. https://jibtherapies.biomedcentral.com/articles/10.1186/1476-8518-3-6
Media Contact:
Craig Stoltz
Mobile: +1 (215) 779-9396
Investor Contact:
Raychel Kruper
Office: +1 (732) 524-6164
 
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-tremfya-guselkumab-post-hoc-analysis-reveals-active-psoriatic-arthritis-patients-with-early-efficacy-had-meaningful-long-term-improvement-in-health-related-quality-of-life-301673947.html
SOURCE Janssen Pharmaceutical Companies of Johnson & Johnson
The things to remember about dementia are that it is absolutely horrible for you and everyone around you; it’s a high probability; and when it comes to fighting it or avoiding it you are pretty much on your own. Alzheimer’s disease and related dementias are currently killing 6.5 million people in the United States and devastating the lives of many times that when you count the patients’ friends and family. The National Institutes of Health reckons this number is likely to double in the next four decades.
Shares of TG Therapeutics (NASDAQ: TGTX) rose 59.9% this week, according to data from S&P Global Market Intelligence. The biopharmaceutical company closed last week at $5.84, which is precisely where it opened this week. MS is an autoimmune disease disease affecting the central nervous system; it generally attacks the brain, spinal cord, and optic nerves.
Approximately 55 million people are living with dementia across the globe, reports the World Health Organization (WHO). And as the proportion of older adults continues to increase worldwide, experts anticipate global dementia rates will rise to 78 million in 2030, and 139 million by 2050.Adopting healthy lifestyle habits can help protect your cognitive health—but one thing may be increasing your dementia risk, in spite of your efforts. Read on to find out what 58 percent of Americans are doing t
When it comes to devastating diseases like Alzheimer's, identifying the risk factors is crucial. Some things, like your age, obviously can't be changed—the Alzheimer's Association reports that most people with Alzheimer's are 65 and older—but other factors are within our control. Practicing good oral hygiene, for example, can go a long way toward protecting your brain health.Studies have also discovered an unsettling connection between an increased risk of dementia and certain medications. Read
Biotech giants Regeneron Pharmaceuticals (NASDAQ: REGN) and Gilead Sciences (NASDAQ: GILD) are among them. Eylea could lose patent protection as early as next year. Why is Regeneron beating the market this year despite these issues?
U.S. extending COVID public health emergency through spring 2023, per official
The family from Northamptonshire have said the soil heap has made their lives a "living hell".
You may not have much of an appetite nor the energy to cook, but eating small, frequent meals and staying hydrated is key.
Fentanyl deaths among teens more than doubled from 2019 to 2020, increasing from 253 to 680. Last year, the number jumped to 884, according to a report from the Journal of the American Medical Assn.
Chief Medical Officers have largely been relegated to executive roles in health care companies, but the pandemic has given corporate America a reason to hire more.
The World Health Organization noted this year that anxiety and depression increased by 25% across the globe in just the first year of the COVID-19 pandemic. And researchers have continued to find more evidence that the coronavirus wreaked havoc on our mental health. In a 2021 study, more than half of American adults reported symptoms of major depressive disorder after a coronavirus infection. The risk of developing these symptoms — as well as other mental health disorders — remains high up to a
A woman has been taken to the hospital with what appear to be non-life threatening injuries after a shooting in downtown Denver.
Different foods have different impacts on the brain.
California's early flu season has begun to putting pressure on local emergency departments forcing hospital to use overflow tents outside emergency rooms.
Amy Schumer almost backed out of hosting "Saturday Night Live" last week after her 3-year-old son, Gene, was rushed to the emergency room for respiratory
New variants, a "tripledemic," and more
Rest in peace to a true legend. Voice actor Kevin Conroy, who brought Batman to life on the small screen for generations of comic book fans, has died at the age of 66. Today in health, we look at President Biden’s reaction to Democrats’ better-than-expected election night and the health care issue he’s crediting for…
As announced by the Health Minister of Germany, Karl Lauterbach, there is proposed legislation to legalize cannabis for recreational use.
What is the COVID-19 situation like in Florida?
Mark Potter, a former NBC News correspondent, has spent the last four years taking pictures of sunrises when he learned his wife was diagnosed with cancer.

source

DarthArt/iStock 
Climate change delegates traveling aboard private jets known to release more carbon dioxide emissions have added to the controversy surrounding the United Nations Climate Change Conference (COP27) in Sharm el-Sheikh, Egypt.
Hundreds of environmental activists stopped private jets from taking off from Amsterdam's Schiphol Airport the day before the conference started last week. 
"I think the activists are right…the few leaders that attended the event, are affecting climate more than helping it by coming on private jets," Dr. Gohram Malghani, associate professor of the Environmental Sciences department at the Balochistan University of Information Technology, Engineering, and Management Sciences (BUITEMS) University, Pakistan, told Interesting Engineering (IE) on Thursday.
"Environmentalists understand that leaders are less interested in climate issues." 
The demonstrators sat in front of the private jets and cycled around the airfield to register their protest. 
zorazhuang/iStock 
Flightradar24, a Swedish online service that displays real-time aircraft flight tracking data, revealed 36 private jets landed in Sharm el-Sheikh between November 4 and 6, before the commencement of the summit.
Additional 64 flights, 24 of which originated in Sharm el-Sheikh, arrived in Cairo.
According to Flightradar24 data, Nine of the flights originated in the United Kingdom, with others from Europe, including Italy, France, and the Netherlands. Two flights arrived in Cairo from the United States, one from Atlanta and one from Washington, DC.
There may have been more scheduled private flights than it was able to capture due to the "limited coverage in the area," noted FlightRadar24. 
However, according to a BBC Reality Check investigation, in 2021, fewer private planes appear to be flying to COP27 than at COP26, which was hosted in Glasgow.
If compared to commercial flights, private planes typically emit much more pollution per passenger. 
"Private jets have a disproportionate impact on the environment. In just one hour, a single private jet can emit two metric tonnes of CO2," according to a report released last year by Transport & Environment, a major European clean transport campaign group.
"The average person in the EU emits 8.2 tons of CO2-eq over the course of an entire year." 
CO2-eq is a metric measure used to compare the emissions from various greenhouse gasses on the basis of their global-warming potential (GWP). 
The Gulfstream G650, which uses roughly 500 gallons (1,893 liters) of gasoline per hour, was the one that was flown into Egypt the most frequently to Cop27, BBC reported. 
Despite the protests, it should have taken a private plane roughly five hours to travel from Amsterdam to Sharm el-Sheikh, burning about 9,465 liters of aviation fuel, as per the Department for Business, Energy and Industrial Strategy (BEIS). 
The output of such a flight would be 23.9 tonnes with every liter of aircraft turbine fuel burned, resulting in the emission of 2.5kg (5.5lb) of CO2. 
Therefore, if all 15 seats were occupied, the total emissions for this flight would be 45.3 tonnes of CO2 equivalent, with each passenger contributing roughly three tonnes to the overall amount.
These emissions values are estimations for the actual flights, they do not account for the emissions generated during the initial production of the private aircraft, according to BBC. 
It is "missing the point" to concentrate on how world leaders traveled to COP27 in private jets, the Energy and Climate Intelligence Unit's lead told BBC. 
He claimed that the impact of the decisions and promises taken at these summits outweighed the emissions.
The event has been marred by inflated lodging charges, human rights violations of the host country, and concerns about Egypt's own climate credentials.
'Even I could not have imagined how late and how over budget it would be,’ Garver said ahead of the launch of Artemis I.

source

Experiverb, Usynth Drive, Proteus: Free plug-ins of the week  ·  Source: Ujam, Gearnews
Experiverb by Audiomodern is a very cool shape-based reverb that’s only available for a limited time, so you’ll need to be quick! This week’s collection of the best free plugins also features Ujam Usynth Drive, a software synth for some banging house tracks, and Proteus, a neat utility that allows you to capture the knobs of your guitar amps or pedals. Enjoy!
Looking for a reverb that ventures a little bit off the beaten path? Don’t miss Experiverb by Audiomodern! The algorithmic reverb is based on various unique and complex shapes. Experiment with the shapes until you find one that matches the sound you have in mind, and then drag it up and down to adjust the depth of the effect. Experiverb also allows you to save your own presets. The developer says that it’ll be “gone forever” after December 4, 2022, so grab it while you can!
Experiverb is available for macOS 10.12 or higher and Windows 10 or higher in VST, VST3, AU, and AAX formats. It requires at least 200 MB of drive space.
Get Experiverb here
Ujam’s Usynth series is all about software synths that pack a full-blown synth engine and sequencer in an easy-to-use shell. Other installments on styles like EDM, Synthwave, or Hip Hop. The latest release, Usynth Drive, is packed with sounds and sequences for house music, and it’s completely free! Each sound consists of two layers and you can jam with the included sequences. If you dare, use the randomize feature to come up with new patterns, and us Ujam’s signature Finisher effects.
Ujam Usynth Drive is available for Windows 10 or higher and macOS 10.14 or higher in VST2, AU, and AAX formats. It doesn’t currently offer native support for Apple Silicon Macs.
Get Usynth Drive here
Proteus by GuitarML is a very cool utility that lets you capture any drive/gain/EQ knob of a guitar amp or pedal as a plugin for your DAW. On the surface, it looks similar to the developer’s older SmartPedal plugin, but it uses new neural-network-based capture technology. There’s a separate capture utility that allows you to record your amp or pedal at different settings, and then turn that into a plugin with two simple knobs for Drive and Level. A library of pre-recorded tones is also available.
Proteus is available for Windows, macOS, and Linux in VST3, AU, and AAX formats.
Get Proteus here
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Load video
Always unblock YouTube
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Load video
Always unblock YouTube
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Load video
Always unblock YouTube
 
How do you like this post?
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website

13 Nov · Thanks for the suggestion, but at close to $500, the Slate VSX is far from being a budget set of headphones.
13 Nov · Gotta say it’s weird as heck not having Slate VSX on this list.
13 Nov · Ahh, love the Prodigy so thank you for putting this together 🙂

source

Here’s How Guitarists Revolutionized Music in the Mid-’60s  Guitar Player
source

Kinross reports 2022 third-quarter results  Kinross Gold Corporation
source

Donald Trump’s lawyers argued Thursday that he could suffer irreparable harm if a special master doesn’t review the documents seized at Mar-a-Lago and urged a federal appeals court to uphold the review.
“This investigation of President Trump by the administration of his political rival is both unprecedented and misguided,” his lawyers James Trusty and Christopher Kise argued. “In what at its core is a document dispute that has spiraled out of control, the Government wrongfully seeks to criminalize the possession by the 45th President of his own Presidential and personal records.”
Trump had won approval in U.S. District Court of the special master to review 11,000 records, more than 100 of which were classified.
The Justice Department seized the records as part of a criminal investigation, but could potentially be blocked from using them because they are personal or fall under executive privilege. Trump has dropped previous potential claims of attorney-client privilege.
The appeals court hasn’t scheduled oral arguments in the case yet.
The Justice Department appealed to the 11th U.S. Circuit Court of Appeals the order from U.S. District Judge Aileen Cannon appointing the special master, U.S. District Judge Raymond Dearie, as “unwarranted.”
Trump has “no plausible claim of executive privilege as to any of the seized materials” and had not demonstrated that provisions to screen out documents that might involve attorney-client communications were “inadequate,” government lawyers argued.
A three-judge panel of the appeals court previously ruled the Justice Department could continue its investigation and not submit the 100 classified documents for Dearie’s review. Trump appealed, but the Supreme Court refused to intervene.
Dearie is scheduled to complete his review by Dec. 16, but the legal wrangling over his appointment continues. He is reviewing documents seized Aug. 8 at Mar-a-Lago, where FBI agents were looking for evidence of violations of the Espionage Act or obstruction of justice.

source

MORGANTOWN, W.Va. — Once again, the Sooners will look to avoid losing multiple games in a row. Once again, they’ll look to become bowl eligible, with a second try after failing last weekend against Baylor.
But even with so much success over the years, this isn’t exactly completely unknown territory for Brent Venables and the Sooners. On this date in 2009, Venables’ third-to-last in Norman before leaving the South Plains for Clemson, the Sooners had four losses. They also endured four losses before that in 2005. They’d finish both of those seasons on a somewhat positive note.
“Yeah, mindset and the continue to invest,” Venables said of those two campaigns. “You know, those are just being a competitor. Like I said, when you’ve invested as much as you have, you just don’t surrender. You know? Again, I pay attention to what’s being said or the opinions. And that’s what you all get paid to do, to go really high with everybody or really down here and get the clickbait and all that kind of stuff. That’s what you do. And whether it’s intentional or not, you know, because I’ve known some people say, ‘Oh, the season’s over. It’s forgotten.’ But those guys in that locker room don’t think that. Us coaches don’t think that. And if that’s the case, why don’t you just end it now? You know what I mean? Because that’s what some people report, which is fine. They’re entitled to do that. But it’s not how you live life, or you’re going to live a bad life or a miserable life.
“So, I think there’s some similarities certainly in the win and loss column. Obviously, you’re six, seven, eight, 10, 11 years building the program and a locker room full of a bunch of guys that have been around here, not only during that season, but for a long period of time, too. So, some of it’s the same, and then some of it’s you’re trying to create. Again, half our roster that hasn’t been here and invested in a really long time. So, what does that investment look like for each individual? You know, that’s a hard thing to gauge. But certainly being consistent with your message and being strong in moments of adversity or loss is incredibly important. And then, again, being able to quantify what just happened and what needs to take place and the things that everybody’s got to be responsible and accountable for I think is important.
“You have to still at the end of the day, appeal to the voice of reason when you’re in a leadership position. And so you’ve not gotta only be about it, but you also have to be able to bring people along with you and make sure that their mindset is where it needs to be.”
So, from a mindset perspective, that figures to be where Oklahoma is at this weekend. At least, that’s where it hopes to be while looking to improve to 6-4.
With all that said, the time has arrived for Oklahoma vs. West Virginia. Follow along now and feel free to interact with all our fellow members throughout all the action.
Get the fastest scores, stats, news, LIVE videos, and more. CLICK HERE to download the CBS Sports Mobile App and get the latest on your team today.
© 2005-2022 CBS INTERACTIVE ALL RIGHTS RESERVED. CBS Sports is a registered trademark of CBS Broadcasting Inc.

source